Tag | Content |
---|
EnhancerAtlas ID | HS187-14473 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr2:202127270-202127970 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx3-2 | MA0122.3 | chr2:202127737-202127750 | GAAACCACTTAAA | + | 6.52 | ONECUT2 | MA0756.1 | chr2:202127865-202127879 | TGTATTGATTTTTA | - | 6.03 | ONECUT3 | MA0757.1 | chr2:202127865-202127879 | TGTATTGATTTTTA | - | 6.33 |
|
| Number of super-enhancer constituents: 20 | ID | Coordinate | Tissue/cell |
SE_09420 | chr2:202120596-202132844 | CD14 | SE_10823 | chr2:202127300-202128005 | CD19_Primary | SE_11371 | chr2:202120217-202133117 | CD20 | SE_12105 | chr2:202127373-202128259 | CD3 | SE_13377 | chr2:202116776-202129469 | CD34_Primary_RO01536 | SE_14154 | chr2:202120890-202128627 | CD34_Primary_RO01549 | SE_14474 | chr2:202116673-202129483 | CD4_Memory_Primary_7pool | SE_15695 | chr2:202124235-202128180 | CD4_Memory_Primary_8pool | SE_16438 | chr2:202121381-202128048 | CD4_Naive_Primary_8pool | SE_17249 | chr2:202120838-202128238 | CD4p_CD225int_CD127p_Tmem | SE_18739 | chr2:202116396-202130372 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19895 | chr2:202118683-202132848 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20230 | chr2:202118728-202133783 | CD56 | SE_20976 | chr2:202120382-202129739 | CD8_Memory_7pool | SE_22176 | chr2:202120569-202129432 | CD8_Naive_8pool | SE_22535 | chr2:202116396-202130749 | CD8_primiary | SE_25525 | chr2:202116247-202130839 | DND41 | SE_43791 | chr2:202120627-202128809 | MM1S | SE_59254 | chr2:202087719-202128531 | Ly3 | SE_66564 | chr2:202126137-202128968 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr2 | 202127455 | 202127600 | chr2 | 202127532 | 202127774 | chr2 | 202127600 | 202127701 |
|
Enhancer Sequence | AAAATTGGGA AAAGGCCACA AAATGTGACC AAAGAATTAC TTCCAAATGG CAAGTTTTTA 60 AGTAATTTTT ATTTTCTTTT TATACTTCTC TGTACTTTCT CTATGAAACA AGTGTTACTT 120 TTACTGTTTT TAGGAACCAA AAATACAAGT ACATTGTTTA AAAAATACTA GCTTAACAAA 180 GTTTCTAGCC CATAAGCTAG TGCAGAAAAT CTAGGTCCCA TAAAACAAGA ACTGCCACAC 240 GATGTCTCTC CCCTTACAGT GCTGGATGGC CCGTTGTTAA TGGTGTCATA AATCCTTTGC 300 AAGTGACTGT TTTCTAGGTA CTATGACTAG AGGGATGTGT AACTTAAGCA AAAAACAAAA 360 AACAGAAAAG GCTGACTATC ATCTGACAGT GTATCCTGGA ACACCTAGGC CAGAGAAGAA 420 GCCACGTTAG CATTTTCCCT TCTAAATGTC AGTTATGATT TGATGGGGAA ACCACTTAAA 480 AAGCATTGTC ACGTTGTTGA AAAGGTAATG AAATGAGTGA GATGAGATGG CTATGGAGGA 540 CGGAGCTATG CGCCAATCTT ATTATATCCA AATTCATGTC ATCTCAGCCT TGGATTGTAT 600 TGATTTTTAT TATATACTGT CAGAAAATGC TATTGAATGT GTAACAAGAG CCTCAAAAAG 660 GTTTATTCAT TTTGACACCA TAATACTACT TTTAGGAAAT 700
|